Chan Gerald 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Chan Gerald
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-01-01+11,199→ 11,199 totalExercise: $31.91Exp: 2032-12-31→ Common Stock (11,199 underlying) - Award
Common Stock
2025-01-01+6,267→ 17,705 total
Footnotes (1)
- [F1]This option was granted on January 1, 2025. The option vests quarterly on the last day of each quarter from the date of grant, subject to his continued service as a director and expires seven years after the date of grant.